Mudassar F et al., 2020-10: Review proposing that antiparasitic drugs including ivermectin reduce mitochondrial oxidative phosphorylation and tumour hypoxia in high-grade glioma, and could be combined with radiotherapy as radiosensitisers.
Current literature provides compelling evidence that these drugs (atovaquone, ivermectin, proguanil, mefloquine, and quinacrine) could be effective against cancers by mechanisms including inhibition of mitochondrial metabolism and tumor hypoxia and inducing DNA damage.
n/a (HTML full text)
Mudassar F et al., 2020-10: Review proposing that antiparasitic drugs including ivermectin reduce mitochondrial oxidative phosphorylation and tumour hypoxia in high-grade glioma, and could be combined with radiotherapy as radiosensitisers. Study type: narrative review (no new primary data). N: n/a. Country: Australia (University of Western Sydney). Dose/route/schedule: n/a (reviews dosing across studies). Declared COI: 'The authors have declared that no conflict of interest exists.' Comparator: n/a. PARTLY SUPPORTS because it is a hypothesis/review rather than a primary demonstration in glioma. Study type: review.
